Michel Atwood
About Michel Atwood
Michel Atwood, age 55, is Interparfums, Inc.’s Chief Financial Officer (since Sept. 6, 2022) and a director first elected at the September 2022 annual meeting; he previously served in senior finance and M&A roles at Estée Lauder and spent over two decades at Procter & Gamble culminating as Divisional CFO of Global Prestige Fragrances . He holds a master’s in software engineering (INSA Lyon), a master’s in international finance (HEC Paris), and is a Certified Management Accountant; he has lived and worked across France, Switzerland, the U.S., Canada, Turkey and Italy . Under his tenure window, company TSR stood at 197.35 at 12/31/24 (base=100 at 12/31/19) and net income rose from $151M (2022) to $203M (2024); the 5‑year TSR also outperformed the company’s peer group in the corporate performance graph (197.35 vs. 101.55 at 12/31/24) . He serves as both an executive officer and board member (not independent), while core board committees (Audit, Compensation, Nominating) are comprised solely of independent directors .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Estée Lauder | Strategic oversight for fragrance category; senior M&A (integration, divestitures); operational accountability for several fragrance brands | 2018–Mar 2022 | Drove cross-brand R&D and supply-chain synergies; oversaw fragrance portfolio initiatives and transactions |
| Independent (M&A advisor/private investor) | Consultant | 2017–2018 | Advised on fragrance license acquisitions and investments |
| Procter & Gamble | Divisional CFO, Global Prestige Fragrances; earlier CFO Global Markets – Prestige; Director of Strategic Planning, Licensing & Acquisition | 1995–2017 | Led global finance teams (90 and 60 staff), shaped prestige fragrance strategy, and spearheaded the Prestige divestiture to Coty |
External Roles
- No current public company directorships or external committee roles disclosed for Mr. Atwood in the proxy; section lists only his IPAR directorship and management role .
Fixed Compensation
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Base Salary ($) | 161,218 | 525,000 | 700,000 |
| Annual Bonus ($) | 150,000 | 125,000 | 125,000 |
| Notes | Joined 9/6/22; salary prorated from $500k | — | CFO has a verbal arrangement: $100k guaranteed bonus + $100k milestone bonus opportunity; 2024 discretionary bonus paid was $125k |
The Compensation Committee emphasizes higher fixed cash for U.S. executives (relative to European operations), with bonuses discretionary and without preset targets to maintain flexibility .
Performance Compensation
Stock Options (CFO-specific awards)
| Grant Date | Type | Shares | Strike ($/sh) | Term | Vesting | Grant-date FV ($) |
|---|---|---|---|---|---|---|
| 12/30/2022 | NQO | 5,000 | 97.84 | 6 yrs | 20% annually starting 1 year post-grant | 101,814 |
| 12/29/2023 | NQO | 4,000 | 147.71 | 6 yrs | 20% annually starting 1 year post-grant | 140,327 |
| 12/31/2024 | NQO | 4,000 | 130.60 | 6 yrs | 20% annually starting 1 year post-grant | 133,251 |
- Plan mechanics: options granted at fair market value, 6‑year term, vest 20% per year after the first anniversary; options generally forfeit at termination (death/disability exceptions per plan) .
- 2024 plan-based disclosure notes the 12/31/24 grant of 4,000 options at $130.60; closing price $131.51 that day .
- No PSUs/RSUs for U.S. executives; IPAR historically has not granted restricted stock to executive officers .
Annual Incentive Structure (U.S.)
| Component | Design | 2024 Outcome |
|---|---|---|
| Guaranteed bonus | $100k per verbal agreement | Paid via discretionary $125k bonus in 2024 (same as 2023) |
| Milestone bonus | $100k opportunity (criteria not disclosed) | Not separately disclosed as paid; only discretionary $125k shown |
| Performance metrics | Primarily discretionary (no preset targets) for U.S.; European operations also discretionary but historically higher bonus mix | Compensation Committee expressly did not tie CAP (pay-versus-performance) to specific financial metrics for 2024 |
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Beneficial ownership (as of July 1, 2025 record set) | 2,800 shares (all underlying options exercisable within 60 days); <1% of shares outstanding |
| Options outstanding (12/31/24) | 2,000 exercisable / 3,000 unexercisable at $97.84 exp. 12/30/28; 800 exercisable / 3,200 unexercisable at $147.71 exp. 12/28/29; 0 exercisable / 4,000 unexercisable at $130.60 exp. 12/30/30 |
| Option exercises in 2024 | None by Atwood (CEO and others exercised; CFO did not) |
| Ownership guidelines | None for executives (no minimum required) |
| Hedging/pledging | Anti‑hedging policy prohibits hedging/monetization; policy requires pre‑clearance and trading windows; no pledging policy disclosed |
| Section 16 compliance | Company reports no late filings for insiders based on Forms 3/4/5 review |
Vesting cadence implies potential incremental sellable supply of ~1,000 options from the 2022 grant vesting annually (2023–2027) and ~800 options from each of the 2023 and 2024 grants (2024/2025–2028/2029), subject to trading windows and personal decisions .
Employment Terms
- Employment agreement: None disclosed for Mr. Atwood (U.S. executives do not have employment agreements; flexibility in base salary cited) .
- Severance/Change‑of‑Control: No severance multiples, CoC triggers, or accelerated vesting terms disclosed for Mr. Atwood; clawback policy (SEC/Nasdaq compliant) applies to incentive-based compensation received on/after Oct. 2, 2023 .
- Non‑compete/non‑solicit/garden leave/post‑termination consulting: Not disclosed for Mr. Atwood (agreements described in detail only for Messrs. Madar and Benacin) .
- Retirement/benefits: U.S. 401(k) with match; no nonqualified deferred comp; no pension benefits for Atwood; no perquisites shown for 2024 .
Board Governance (Director Service, Committees, Independence)
- Board service: Director since Sept. 2022; CFO and director (management director; not independent) .
- Board committees: Audit, Executive Compensation & Stock Option, and Nominating Committees composed entirely of independent directors; chairs: François Heilbronn (all three) .
- Attendance: Board held 23 meetings (incl. committee) in 2024; all directors attended at least 75% of meetings/consents of the full board and relevant committees .
- Leadership/independence context: CEO is also Chairman; Board has no Lead Independent Director; board notes comfort with dual leadership given large owner-operators (Madar/Benacin) and segment oversight split; Atwood’s dual role (CFO + director) is standard for management directors but reduces board independence composition at the margin .
Director Compensation (Context)
- Director fees/equity apply to non‑employee directors only (meeting fees and annual option grants of 1,500 shares in 2024); employee directors (e.g., CFO) are compensated through executive pay, not director retainers .
Compensation Structure Analysis
- Cash vs. equity mix: U.S. CFO pay is salary‑heavy with modest discretionary cash bonus; equity awards are annual stock options (no RSUs/PSUs) with fair values of ~$102k (2022), ~$140k (2023), ~$133k (2024) .
- Performance linkage: Company explicitly did not use financial performance measures to link “Compensation Actually Paid” to company performance for 2024; U.S. bonuses are discretionary without preset targets, indicating limited formulaic pay‑for‑performance rigor for CFO cash pay .
- Repricing/modification: No option repricings disclosed; options issued at fair market value with 6‑year terms and standard vesting .
- Clawback/hedging controls: SEC/Nasdaq‑compliant clawback policy in effect; robust anti‑hedging policy and strict trading windows/pre‑clearance .
- Ownership alignment: No executive ownership guidelines (uncommon among mid/large‑cap peers), but Atwood’s equity exposure comes via multi‑year option grants; no pledging disclosure .
Key Multi‑Year Data
CFO – Summary Compensation
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Salary ($) | 161,218 | 525,000 | 700,000 |
| Bonus ($) | 150,000 | 125,000 | 125,000 |
| Option Awards (Grant‑date FV, $) | 101,814 | 140,327 | 133,251 |
| Total ($) | 413,032 | 790,327 | 958,251 |
Equity – Outstanding Options (12/31/24)
| Option Tranche | Exercisable | Unexercisable | Strike ($) | Expiration |
|---|---|---|---|---|
| 12/30/2022 grant | 2,000 | 3,000 | 97.84 | 12/30/2028 |
| 12/29/2023 grant | 800 | 3,200 | 147.71 | 12/28/2029 |
| 12/31/2024 grant | 0 | 4,000 | 130.60 | 12/30/2030 |
Pay vs Performance (Company-level context)
| Year | TSR ($, $100 base at 12/31/19) | Peer Group TSR ($) | Net Income ($M) |
|---|---|---|---|
| 2020 | 83.75 | 118.87 | 50 |
| 2021 | 149.91 | 145.11 | 110 |
| 2022 | 138.82 | 116.33 | 151 |
| 2023 | 210.93 | 114.95 | 188 |
| 2024 | 197.35 | 101.55 | 203 |
The company also reports a custom peer set for pay‑versus‑performance (PVP) disclosure and notes that 2024 compensation actually paid was not tied to a company‑selected financial measure; the PVP table shows TSR of 197.35 and custom peer TSR of 147.04 for 2024 .
Compensation Committee & Peer Group
- Committee composition: Independent directors François Heilbronn (Chair), Robert Bensoussan, and Veronique Gabai‑Pinsky; broad reliance on experience rather than formal benchmarking or outside consultants for executive pay .
- Peer group for performance graph updated in 2023 to reflect current competitive landscape (e.g., ELC, P&G, e.l.f. Beauty, Coty, L’Oréal, LVMH, Natura, Olaplex, Shiseido) .
- Say‑on‑pay: 2024 shareholder advisory vote “overwhelmingly approved” compensation policies and decisions .
Risk Indicators & Red Flags
- Governance structure: CEO also Chairman; no Lead Independent Director; management directors include the CFO; core committees remain fully independent .
- Ownership policy: No executive stock ownership guidelines (potential alignment gap); anti‑hedging in place; pledging policy not disclosed .
- Related‑party transactions: Intercompany loans between subsidiaries and the parent to fund dividends/repurchases in 2023–2024; approved and disclosed, but notable from a governance optics standpoint .
- Clawback: SEC/Nasdaq‑compliant clawback policy adopted (covers three prior fiscal years for incentive‑based compensation after restatement trigger) .
- Section 16 compliance: No late filings reported for 2024 .
- Option repricing: None disclosed .
Say‑on‑Pay & Shareholder Feedback
- The Compensation Committee cited the “overwhelming” approval of the 2024 say‑on‑pay vote and maintained current policies (discretionary bonuses, options for long‑term) .
Expertise & Qualifications
- Degrees: Master’s in software engineering (INSA Lyon) and master’s in international finance (HEC Paris); CMA designation .
- Domain expertise: Finance leadership (Divisional CFO), fragrance industry strategy and M&A (P&G, Estée Lauder), global operating experience .
Work History & Career Trajectory
- 2022–Present: CFO, Interparfums, Inc.; director since Sept. 2022 .
- 2018–2022: Estée Lauder – fragrance category strategy and brand operations; senior M&A integration and divestitures .
- 2017–2018: Independent M&A advisor/private investor .
- 1995–2017: P&G – Divisional CFO Global Prestige Fragrances; prior roles in strategy, licensing, acquisitions; CFO Global Markets – Prestige .
Investment Implications
- Alignment and retention: Atwood’s pay mix is salary‑heavy with modest annual options; absence of stock ownership guidelines and discretionary bonus design limit explicit pay‑for‑performance alignment, though multi‑year options provide leverage to share price; no disclosed severance/CoC protections could be a retention risk vs large‑cap peers offering formal arrangements .
- Trading/overhang signals: Option vesting cadence (1,000 from 2022 grant annually; ~800 from 2023/2024 grants annually on their schedules) creates periodic potential liquidity events but pre‑clearance and blackout windows constrain timing; no 2024 option exercises by Atwood .
- Governance considerations: Dual roles (CFO + director) and combined CEO/Chair with no Lead Independent Director warrant monitoring; committees remain fully independent; say‑on‑pay support was strong .
- Performance backdrop: 5‑year TSR and net income trajectory are favorable; company states CAP not tied to financial metrics in 2024 (reduces direct pay‑performance sensitivity), but long‑term options maintain upside linkage to equity performance .